Edition:
United Kingdom

GlaxoSmithKline Consumer Healthcare Ltd (GLSM.NS)

GLSM.NS on National Stock Exchange of India

6,218.80INR
23 May 2018
Change (% chg)

Rs282.40 (+4.76%)
Prev Close
Rs5,936.40
Open
Rs6,000.00
Day's High
Rs6,284.00
Day's Low
Rs5,951.55
Volume
55,066
Avg. Vol
18,403
52-wk High
Rs6,940.25
52-wk Low
Rs4,851.00

Chart for

About

GlaxoSmithKline Consumer Healthcare Limited is a food processing company. The Company offers malt-based food, protein rich food, cereal-based beverage and nutritional food powder. Its products include nutritional products and over the counter (OTC) products. The Company's nutritional products include Horlicks Ninja, Junior... (more)

Overall

Beta: 0.72
Market Cap(Mil.): Rs210,178.91
Shares Outstanding(Mil.): 42.06
Dividend: 70.00
Yield (%): 1.40

Financials

  GLSM.NS Industry Sector
P/E (TTM): 33.45 22.60 40.93
EPS (TTM): 149.40 -- --
ROI: -- 12.23 62.10
ROE: -- 15.60 73.67

GSK buys out Novartis in $13 billion consumer healthcare shake-up

FRANKFURT/ZURICH GlaxoSmithKline is buying Novartis out of their consumer healthcare joint venture for $13 billion (9 billion pounds), taking full control of products including Sensodyne toothpaste, Panadol headache tablets, muscle gel Voltaren, and Nicotinell patches. | Video

27 Mar 2018

GSK buys out Novartis in $13 billion consumer healthcare shake-up

FRANKFURT/ZURICH GlaxoSmithKline is buying Novartis out of their consumer healthcare joint venture for $13 billion, taking full control of products including Sensodyne toothpaste, Panadol headache tablets, muscle gel Voltaren, and Nicotinell patches. | Video

27 Mar 2018

UPDATE 4-GSK buys out Novartis in $13 bln consumer healthcare shake-up

* Deal unravels JV agreed in 2014 (Adds fund manager quote, background on new Novartis CEO)

27 Mar 2018

BRIEF-India's GlaxoSmithKline Consumer Healthcare Dec Qtr Profit Up 20 Pct

* DEC QUARTER PROFIT 1.64 BILLION RUPEES VERSUS PROFIT OF 1.36 BILLION RUPEES LAST YEAR

12 Feb 2018

BRIEF-Neurometrix, Glaxosmithkline Announce Collaboration To Develop Quell Wearable Pain Relief Technology

* NEUROMETRIX AND GLAXOSMITHKLINE CONSUMER HEALTHCARE ANNOUNCE STRATEGIC COLLABORATION TO DEVELOP AND EXPAND ACCESS TO QUELL WEARABLE PAIN RELIEF TECHNOLOGY

17 Jan 2018

Earnings vs. Estimates